Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Beam Global (BEEM)

8-K Earnings release confidence 98% filed 2026-08-19 Item 2.02

This is a straightforward earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 19, 2026. Item 2.02 discloses quarterly financial results with a press release attached as Exhibit 99.1 showing Q2 2026 revenue of $8.6M (174% increase over Q1 2026, 21% YoY growth), gross margin of 17.8%, and net loss of $3.1M. The filing explicitly states "On August 19, 2026, Beam Global (the 'Company') issued a press release announcing financial results for its quarter ended June 30, 2026." This is material to investors as it provides the company's quarterly operating results and financial condition.

View raw filing on EDGAR →

INTELLIGENT BIO SOLUTIONS INC. (INBS)

8-K Earnings release confidence 95% filed 2026-08-19

The 8-K discloses under Item 2.02 a press release announcing financial results for the three months and full fiscal year ended June 30, 2026. The press release reports record annual revenue of $4.2 million (38% YoY growth), gross profit of $2.05 million (64% YoY growth), and gross margin expansion to 48.63% (778 basis points improvement). Consolidated financial statements are included showing revenue, cost of revenue, operating expenses, and net loss. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.

View raw filing on EDGAR →

SRX Global Inc. (SRXH)

8-K Earnings release confidence 95% filed 2026-08-19 Item 2.02

This is a clear earnings release for fiscal Q3 2026 (ended June 30, 2026) filed under Item 2.02. The press release (Exhibit 99.1) discloses quarterly financial results including net sales of $3.4 million (27% YoY growth), operating loss of $3.2 million (63% improvement YoY), net loss from continuing operations of $4.1 million (40% improvement YoY), and detailed balance sheet metrics including NAV of $62.9 million or $3.22 per share. The filing includes unaudited condensed consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.

View raw filing on EDGAR →

Flex LNG Ltd. (FLNG)

6-K Earnings release confidence 95% filed 2026-08-19 EX-99.1

This exhibit is a press release announcing Flex LNG's unaudited financial results for the second quarter 2026 (quarter ended June 30, 2026), dated August 19, 2026. It discloses vessel operating revenues of $106.8 million, net income of $44.9 million, earnings per share of $0.83, and provides forward guidance for full-year 2026 revenue ($345–$370 million) and adjusted EBITDA ($255–$280 million). The document also announces a quarterly dividend of $0.75 per share. This is a discrete earnings announcement, not a periodic financial report, and the results are material to investors assessing the registrant's financial performance and cash generation.

View raw filing on EDGAR →

Carlyle Credit Income Fund (CCID)

8-K Earnings release confidence 95% filed 2026-08-19 Item 2.02

Carlyle Credit Income Fund issued a summary press release and detailed earnings presentation on August 19, 2026, announcing third quarter 2026 financial results. The disclosure includes key metrics such as net investment income per share ($0.07 GAAP, $0.09 adjusted, $0.25 core), net asset value per share ($3.32), and total fair value of investments ($118.9 million), along with dividend declarations. This is a standard quarterly earnings release filed under Item 2.02, material to investors assessing the fund's financial performance and dividend sustainability.

View raw filing on EDGAR →

BILL Holdings, Inc. (BILL)

8-K Earnings release confidence 98% filed 2026-08-19 Item 2.02

BILL Holdings issued a press release on August 19, 2026 disclosing financial results for the fourth quarter and fiscal year ended June 30, 2026. The disclosure includes detailed revenue metrics (FY26 total revenue of $1.7 billion, up 13% YoY; core revenue of $1.5 billion, up 16% YoY), profitability measures, and forward guidance for Q1 and FY27. The press release is furnished as Exhibit 99.1 and represents a standard earnings announcement with both GAAP and non-GAAP reconciliations, typical of Item 2.02 disclosures.

View raw filing on EDGAR →

Alvotech (ALVOW)

6-K Earnings release confidence 95% filed 2026-08-19 EX-99.3

This is a press release announcing Alvotech's financial results for the first half of 2026, including adjusted total revenue of $211.9 million (down 30.8% YoY), adjusted EBITDA of $46.9 million, and cash balance of $142.8 million. The disclosure includes H1 2026 financial highlights, Q2 business highlights (FDA resubmissions, facility inspection results, equity financing), CEO commentary, and full-year 2026 guidance ($650-700M revenue, $180-220M adjusted EBITDA). This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance and regulatory progress.

View raw filing on EDGAR →

Telix Pharmaceuticals Ltd (TLPPF)

6-K Earnings release confidence 95% filed 2026-08-19 EX-99.3

This is a half-year financial results announcement for Telix Pharmaceuticals for the period ended June 30, 2026. The exhibit discloses key financial metrics including revenue of US$477 million (up 22% year-over-year), gross margin of 55%, adjusted EBITDA of US$52 million, and profit after tax of US$38 million, along with segment performance and operational milestones. This is a discrete earnings event, not a periodic financial report itself, and would materially affect investor assessment of the company's financial performance and commercial execution.

View raw filing on EDGAR →

MEDICURE INC (MCUJF)

6-K Earnings release confidence 95% filed 2026-08-19 EX-99.1

This is a press release disclosing Medicure's quarterly financial results for the period ended June 30, 2026. The document presents net revenue of $7.4 million, net loss of $1.4 million ($0.14 per share), and adjusted EBITDA of $172,000, along with detailed segment performance and cash position. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and schedules a conference call to discuss results, which are hallmarks of an earnings release event.

View raw filing on EDGAR →

Opera Ltd (OPRA)

6-K Earnings release confidence 98% filed 2026-08-19 EX-99.1

This is a press release announcing Opera's second quarter 2026 financial results, with revenue of $178.1 million (25% YoY growth) and adjusted EBITDA of $42.4 million (32% YoY growth), both exceeding guidance ranges. The release includes detailed financial statements, business highlights, and updated full-year 2026 guidance. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the registrant's financial performance and trajectory.

View raw filing on EDGAR →

Viking Holdings Ltd (VIK)

6-K Earnings release confidence 98% filed 2026-08-19 EX-99.1

This is a press release announcing Viking Holdings Ltd's second quarter 2026 financial results, including revenue of $2,190.5 million (up 16.5% YoY), Adjusted EBITDA of $748.4 million (up 18.2% YoY), and Diluted EPS of $1.31. The exhibit includes consolidated interim financial statements (income statement, balance sheet, cash flows) and detailed operational metrics. This is a classic earnings release disclosing quarterly financial performance and is material to investors assessing the registrant's financial condition and operating trends.

View raw filing on EDGAR →

Ionic Digital Inc.

8-K Earnings release confidence 98% filed 2026-08-19 Item 2.02

Item 2.02 discloses Ionic Digital's second quarter 2026 financial results via a press release furnished as Exhibit 99.1. The filing announces Q2 revenue of $48.6 million (31% YoY growth), gross profit of $40.5 million, and Adjusted EBITDA of $37.6 million, along with full-year 2026 guidance. This is a standard earnings release disclosure material to investors assessing the company's operational and financial performance.

View raw filing on EDGAR →

Lufax Holding Ltd (LU)

6-K Earnings release confidence 95% filed 2026-08-18 EX-99.1

This is a press release announcing Lufax's unaudited financial results for the second quarter and first half of 2026, including detailed income statements, balance sheet data, and operational metrics. The document explicitly states "Lufax Reports Second Quarter 2026 Financial Results" and provides comprehensive financial disclosures (total income RMB6,227 million, net loss RMB82 million) alongside operational highlights. This is a discrete earnings announcement, not a periodic financial report filing itself, and represents a material event as the company explicitly notes it marks "an important milestone" in returning to normal reporting cadence after prior audit issues.

View raw filing on EDGAR →

HIVE Digital Technologies Ltd. (HIVE)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

HIVE Digital Technologies issued a press release on August 15, 2026, announcing financial results for Q1 fiscal 2027 (ended June 30, 2026). The disclosure reports total revenue of $79.1 million (up 73.5% year-over-year), digital currency revenue of $72.1 million, HPC revenue of $7.1 million, gross operating margin of $24.2 million, and Adjusted EBITDA of $13.4 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, disclosing comprehensive financial results and operational metrics material to investors.

View raw filing on EDGAR →

EMPIRE PETROLEUM CORP (EP)

8-K Earnings release confidence 95% filed 2026-08-17

Empire Petroleum issued a press release on August 17, 2026, announcing financial and operating results for Q2 2026, disclosing net product revenue of $11.1 million, net loss of $1.9 million (or $0.05 per diluted share), and Adjusted EBITDA of $0.4 million. This is a standard quarterly earnings release filed under Item 2.02 of Form 8-K with the press release furnished as Exhibit 99.

View raw filing on EDGAR →

MINISO Group Holding Ltd (MSOGF)

6-K Earnings release confidence 75% filed 2026-08-17 EX-99.1

This is an announcement of an upcoming earnings release for the 2026 June quarter and interim financial results, scheduled for August 28, 2026. While the actual financial results have not yet been disclosed, the announcement itself signals a material periodic financial event. The company explicitly states it "plans to release its 2026 June quarter and interim financial results" and is scheduling a management earnings conference call to discuss those results, which is the standard disclosure pattern for earnings announcements. However, confidence is moderate (0.75) rather than high because this is technically an announcement *of* an earnings release rather than the release itself—the actual results will be furnished separately on August 28.

View raw filing on EDGAR →

Freightos Ltd (CRGOW)

6-K Earnings release confidence 98% filed 2026-08-17 EX-99.1

This is a press release announcing Freightos' second quarter 2026 financial results, including record revenue of $7.7 million, gross margin metrics, IFRS loss, Adjusted EBITDA, cash position, and forward-looking guidance for Q3 and full-year 2026. The exhibit contains consolidated balance sheets, statements of operations, and cash flows for the periods ended June 30, 2026, which are characteristic of a quarterly earnings release. Material to investors assessing the company's financial performance and trajectory toward profitability.

View raw filing on EDGAR →

UNITED STATES ANTIMONY CORP (UAMY)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

This Item 2.02 disclosure reports United States Antimony Corporation's second quarter 2026 financial and operational results via a conference call held on August 11, 2026. The filing furnishes a transcript of the earnings presentation (Exhibit 99.1) detailing Q2 2026 revenue of $7.9 million (down 25% YoY), gross profit of $0.6 million, operating loss of $7 million, and net income of $0.1 million, along with balance sheet metrics including $41.4 million in cash and $62.2 million in total liquidity. This is a standard earnings release disclosure under Item 2.02.

View raw filing on EDGAR →

Vuzix Corp (VUZI)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

This is a straightforward earnings release disclosing Vuzix's second quarter 2026 financial results for the period ended June 30, 2026. The press release, attached as Exhibit 99.1, presents condensed consolidated statements of operations data, revenue comparisons, expense analysis, net loss per share ($0.09 vs. $0.10 prior year), and cash position ($17.3 million with no debt). The filing is made under Item 2.02 (Results of Operations and Financial Condition), the standard Item for earnings disclosures.

View raw filing on EDGAR →

Prairie Operating Co. (PROP)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

Prairie Operating Co. announced its financial results for the quarter ended June 30, 2026 via press release on August 17, 2026, disclosing Q2 2026 revenue of $98.9 million (up 45% YoY), net income of $193.8 million, and adjusted EBITDA of $34.0 million. The full press release is attached as Exhibit 99.1 and contains detailed financial statements, production metrics, and forward guidance, which is the hallmark of an earnings release under Item 2.02.

View raw filing on EDGAR →

CREDICORP LTD (BAP)

6-K Earnings release confidence 98% filed 2026-08-17 EX-99.1

This is a formal earnings release for Credicorp Ltd.'s second quarter 2026 results, dated August 13, 2026, disclosing consolidated financial and operating results including net income of S/1,981.9 million, ROE of 20.3%, loan growth of 13.1% YoY, and updated medium-term ROE guidance to 22.0%. The document explicitly states "Credicorp Ltd. Reports Financial and Operating Results for 2Q26" and contains detailed financial tables, management commentary, and forward guidance typical of a quarterly earnings announcement.

View raw filing on EDGAR →

Rubico Inc. (RUBI)

6-K Earnings release confidence 95% filed 2026-08-17 EX-99.1

This is a press release announcing Rubico Inc.'s financial results for the six months ended June 30, 2026, disclosing a net loss of $1.1 million, revenues of $9.7 million, operating cash flow of $4.1 million, and key balance-sheet metrics. The document explicitly states "announced today its financial results" and references the unaudited interim condensed consolidated financial statements filed on Form 6-K, making this a classic interim earnings release. Material to investors assessing the company's operational and financial performance.

View raw filing on EDGAR →

GENERATION INCOME PROPERTIES, INC. (GIPRW)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

Generation Income Properties disclosed its second quarter 2026 financial results via press release on August 17, 2026, reporting net loss attributable to common shareholders of $1.08 million for Q2 2026 (down 76% from $4.42 million in Q2 2025) and six-month net loss of $3.21 million, along with key operational metrics.

View raw filing on EDGAR →

FLEXSTEEL INDUSTRIES INC (FLXS)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

Flexsteel Industries issued a press release on August 17, 2026 announcing fourth quarter and fiscal year 2026 operating results, including net sales of $459.2 million (4.1% growth), GAAP net income of $33.1 million, and record adjusted diluted EPS of $4.94, along with forward guidance for Q1 FY2027.

View raw filing on EDGAR →

Bitfufu Inc. (FUFUW)

6-K Earnings release confidence 98% filed 2026-08-17 EX-99.1

This is a press release announcing BitFuFu's unaudited second quarter 2026 financial results, including revenue ($42.8M, down 62.9% YoY), net loss ($20.5M vs. net income of $47.1M in Q2 2025), and adjusted EBITDA (negative $18.4M). The document contains condensed consolidated financial statements and is clearly a discrete earnings announcement, not a periodic financial report filing. The substantial revenue decline and shift from profitability to loss are material to investors.

View raw filing on EDGAR →

ADIAL PHARMACEUTICALS, INC. (ADIL)

8-K Earnings release confidence 92% filed 2026-08-17 Item 2.02

The filing discloses quarterly financial results for Q2 2026 (ended June 30, 2026) via a press release attached as Exhibit 99.1. The Item 2.02 section explicitly states the Company "issued a press release that included financial information for its quarter ended June 30, 2026," and the press release reports key metrics including cash position ($28.7M), R&D expenses ($440K), G&A expenses ($5.4M), net loss ($52.0M), and loss per share ($(11.25)). While the filing also discloses concurrent M&A activity (Azora acquisition) and financing, the Item 2.02 classification and the press release structure center on the quarterly earnings disclosure.

View raw filing on EDGAR →

Functional Brands Inc. (MEHA)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release attached as Exhibit 99.1 under Item 2.02. The filing presents comprehensive financial results including revenue ($1.87M, up 2%), gross profit, operating loss, and net loss ($2.6M), along with balance sheet and cash flow statements. The disclosure is material as it reveals significant operational challenges including widening losses, going-concern doubts, Nasdaq delisting, and termination of the BullionFX acquisition letter of intent.

View raw filing on EDGAR →

20/20 Biolabs, Inc. (AIDX)

8-K Earnings release confidence 95% filed 2026-08-17

The 8-K discloses under Item 2.02 the Company's financial results for Q2 2026 ended June 30, 2026, with a press release attached as Exhibit 99.1. The press release reports Q2 revenue of $0.7 million (up 36.5% YoY), gross profit of $0.3 million (up 86.6% YoY), and gross margin expansion to 41.7% from 30.5%, along with operational highlights including state-funded firefighter screening programs and cash position strengthening to $4.5 million. This is a standard quarterly earnings disclosure material to investors assessing the registrant's financial performance and trajectory.

View raw filing on EDGAR →

QDM International Inc. (QDMI)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

QDM International Inc. issued a press release on August 17, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $8.4 million (up 133.4% year-over-year), net income of $3.2 million (up 70.2%), and basic EPS of $0.36 (up from $0.22), along with condensed consolidated financial statements.

View raw filing on EDGAR →

Fabrinet (FN)

8-K Earnings release confidence 97% filed 2026-08-17 Item 2.02

Fabrinet issued a press release on August 17, 2026 disclosing financial results for the fourth quarter and fiscal year ended June 26, 2026, including record quarterly revenue of $1.316 billion (45% YoY growth) and record fiscal year revenue of $4.6 billion (36% YoY growth), along with forward guidance for Q1 FY2027.

View raw filing on EDGAR →

QumulusAI, Inc. (QMLS)

8-K Earnings release confidence 90% filed 2026-08-17 Item 2.02

QumulusAI disclosed preliminary financial results for Q2 2026, including cash of approximately $19.97 million and gross profit figures for the three and six-month periods ended June 30, 2026. The company announced its intention to report full second quarter 2026 financial results on August 25, 2026, and host a conference call to discuss results, marking the company's first quarterly results call as a public company.

View raw filing on EDGAR →

Nuo Therapeutics, Inc. (AURX)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

This is a straightforward earnings release disclosing Q2 2026 financial results for Nuo Therapeutics. The filing explicitly states "On August 17, 2026, Nuo Therapeutics, Inc. issued a press release announcing its financial results for the second quarter of 2026" under Item 2.02. The press release includes consolidated balance sheets and statements of operations showing revenue of $1.77M (Q2) and $3.07M (H1 2026), both up over 150% year-over-year, along with operational metrics and business updates. This is material to investors assessing the company's financial performance and trajectory.

View raw filing on EDGAR →

PATRIOT NATIONAL BANCORP INC (PNBK)

8-K Earnings release confidence 85% filed 2026-08-17 Item 7.01

The Company posted Q2 2026 financial information on its Investor Relations website and furnished a presentation as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). While technically a Reg FD disclosure rather than a formal earnings release, the substance is disclosure of quarterly financial results to investors, which is material to a reasonable investor's assessment of the registrant's financial performance and condition.

View raw filing on EDGAR →

NRX Pharmaceuticals, Inc. (NRXPW)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

NRx Pharmaceuticals disclosed its second quarter 2026 financial results via press release on August 17, 2026, as required under Item 2.02. The filing reports net loss of $18.0 million for the six months ended June 30, 2026 (versus $23.1 million in the prior year), net operating loss of $11.3 million, and cash position of $26.7 million as of June 30, 2026. The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings announcement.

View raw filing on EDGAR →

BLUE DOLPHIN ENERGY CO (BDCO)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

Blue Dolphin Energy Company disclosed its quarterly and six-month financial results for the period ended June 30, 2026 via a press release attached as Exhibit 99.1. The disclosure includes net income of $17.7 million ($1.19 per share) for Q2 2026 and $32.5 million ($2.18 per share) for the six-month period, along with gross profit, EBITDA, and liquidity metrics. This is a standard earnings release filed under Item 2.02 and represents material financial results that would affect a reasonable investor's assessment of the company's performance.

View raw filing on EDGAR →

Santacruz Silver Mining Ltd. (SCZM)

6-K Earnings release confidence 98% filed 2026-08-17 EX-99.5

This is a news release dated August 17, 2026, announcing Santacruz Silver Mining's second quarter 2026 financial results. The document discloses Q2 2026 revenues of $113.5 million (55% YoY increase), gross profit of $51.1 million (102% YoY increase), adjusted EBITDA of $46.7 million (74% YoY increase), and net income of $2.0 million. It includes detailed operational and financial highlights, reconciliation tables, and management commentary on performance drivers. This is a classic earnings release announcing quarterly financial results, material to investors assessing the company's financial performance and operational trajectory.

View raw filing on EDGAR →

InspireMD, Inc. (NSPR)

8-K Earnings release confidence 95% filed 2026-08-17

The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing InspireMD's financial and operating results for the three and six months ended June 30, 2026. The filing includes detailed quarterly revenue ($1.8M Q2 2026), gross loss/profit metrics, operating expenses, net loss ($14.3M Q2, $28.0M six months), and per-share results, along with business highlights including product recalls, clinical trial outcomes, and cost-reduction initiatives. This is a standard earnings release disclosure.

View raw filing on EDGAR →

NEXGEL, INC. (NXGLW)

8-K Earnings release confidence 95% filed 2026-08-17

The 8-K discloses NexGel's second quarter 2026 financial results under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 revenue of $3.69 million and a net loss of $2.87 million for the period ending June 30, 2026, along with operational updates regarding the Celularity acquisition integration and strategic initiatives. This is a standard quarterly earnings release material to investors assessing the company's financial performance.

View raw filing on EDGAR →

INVO Fertility, Inc. (IVF)

8-K Earnings release confidence 98% filed 2026-08-17

The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing Q2 2026 financial results for INVO Fertility. The filing reports revenue of $2.2 million (17% increase YoY), clinic-level Adjusted EBITDA profitability of $333,000, and net income of $0.9 million. This is a standard quarterly earnings release with detailed financial statements and management commentary, clearly material to investors assessing the company's operational performance and financial condition.

View raw filing on EDGAR →

Nasus Pharma Ltd (NSRX)

6-K Earnings release confidence 92% filed 2026-08-17 EX-99.3

This exhibit is a press release announcing Nasus Pharma's first-half 2026 financial results, including unaudited interim condensed consolidated balance sheets and statements of operations for the six months ended June 30, 2026. The disclosure includes key financial metrics (cash position of $11.9 million, R&D expenses of $2.6 million, net loss of $5.9 million) and clinical program updates. While the exhibit also mentions the appointment of Brendan O'Grady as CEO, the primary substance is the financial results announcement, making this an earnings_release rather than an exec_appointment event.

View raw filing on EDGAR →

AMC Robotics Corp (AMCI)

8-K Earnings release confidence 95% filed 2026-08-17

The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing AMC Robotics' financial results for Q2 2026 ended June 30, 2026. The filing includes detailed consolidated statements of operations, balance sheets, and cash flows, along with management commentary on revenue trends, gross margin expansion to 80%, and strategic initiatives. This is a standard quarterly earnings release material to investors assessing the company's financial performance.

View raw filing on EDGAR →

PIONEER POWER SOLUTIONS, INC. (PPSI)

8-K Earnings release confidence 95% filed 2026-08-17

Pioneer Power Solutions issued a press release on August 17, 2026, announcing financial results for the second fiscal quarter ended June 30, 2026. The filing discloses Q2 2026 revenue of $5.0 million (down 40% YoY), net loss of $2.1 million, backlog growth to $18.4 million, and management's outlook for H2 2026 revenue of approximately $15 million. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's operational and financial performance.

View raw filing on EDGAR →

Perfect Moment Ltd. (PMNT)

8-K Earnings release confidence 95% filed 2026-08-17

The 8-K discloses financial results for Perfect Moment's fiscal Q1 2027 (ended June 30, 2026) via Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The press release contains detailed financial highlights, condensed consolidated statements of operations, balance sheet data, and management commentary on quarterly performance—all hallmarks of an earnings release.

View raw filing on EDGAR →

AMASS BRANDS (AMSS)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

AMASS Brands issued a press release on August 17, 2026 announcing financial results for Q2 2026 ended June 30, 2026, disclosing net revenue of $5.6 million (up 2% YoY), gross profit of $1.5 million, and adjusted EBITDA of $(1.7) million. The filing also includes initial financial guidance for Q3, full-year 2026, and fiscal 2027. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.

View raw filing on EDGAR →

DocGo Inc. (DCGO)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

DocGo announced Q2 2026 earnings results (ended June 30, 2026) reporting total revenue of $73.4 million, net loss of $18.0 million, and adjusted EBITDA of ($6.3) million, along with revised full-year 2026 guidance.

View raw filing on EDGAR →

ASTRAZENECA PLC (AZN)

6-K Earnings release confidence 75% filed 2026-08-17

This 6-K furnishes a press release announcing positive Phase III trial results (SAFFRON) for Tagrisso plus Orpathys in EGFRm lung cancer, showing statistically significant improvements in progression-free and overall survival. While technically a clinical trial result rather than financial earnings, this disclosure of material clinical efficacy data for a key oncology product would affect a reasonable investor's assessment of the registrant's pipeline and commercial prospects. The announcement emphasizes this as "the first global Phase III trial to show significant progression-free and overall survival benefits in this setting," reinforcing its materiality to the company's oncology strategy.

View raw filing on EDGAR →

WIDEPOINT CORP (WYY)

8-K Earnings release confidence 95% filed 2026-08-17 Item 2.02

WidePoint Corporation disclosed financial results for the six-month and quarter periods ended June 30, 2026 via a press release (Exhibit 99.2) and earnings call transcript (Exhibit 99.1) filed under Item 2.02. This is a standard earnings release disclosure announcing quarterly and interim financial results.

View raw filing on EDGAR →

CLOUDASTRUCTURE, INC. (CSAI)

8-K Earnings release confidence 98% filed 2026-08-17 Item 2.02

Cloudastructure reported Q2 2026 financial results with quarterly revenue of $1.2 million (13% YoY growth), subscription revenue growth of 164% YoY, gross profit of $610,000 (53% YoY growth), and narrowed net loss to $1.7 million.

View raw filing on EDGAR →

AIR T INC (AIRTP)

8-K Earnings release confidence 98% filed 2026-08-14 Item 2.02

Air T, Inc. issued a press release on August 14, 2026 announcing financial results for the quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($115.5 million), operating loss ($12.8 million), net loss per share ($5.86), and Adjusted EBITDA ($0.8 million) with segment-by-segment performance analysis. This is a standard earnings release furnished as Exhibit 99.1 under Item 2.02, disclosing material quarterly financial results that would affect a reasonable investor's assessment of the company's performance.

View raw filing on EDGAR →

AIR T INC (AIRTP)

8-K Earnings release confidence 95% filed 2026-08-14 Item 2.02

Air T, Inc. issued a press release on August 14, 2026 disclosing its financial results for fiscal 2027 first quarter ended June 30, 2026, reporting revenues of $115.5 million (up 63% year-over-year), an operating loss of $12.8 million, and Adjusted EBITDA of $0.8 million.

View raw filing on EDGAR →